delete The National Health Service (General Medical Services) Amendment (No. 2) Regulations 1997
This SI amends the NHS (General Medical Services) Regulations 1992 by revising Schedule 10 (products prohibited from NHS prescription) and Schedule 11 (products restricted to certain circumstances). It removes 59 entries from the prohibited list (liberating them for NHS prescribing) and adds approximately 340 new entries to the prohibited list, while adding Locabiotal Aerosol to Schedule 11 with restricted prescribing conditions. The regulation came into force July 1, 1997.
This regulation represents central planning of pharmaceutical access — a bureaucratic blacklist determining which products doctors may prescribe and patients may receive at NHS expense. It restricts patient choice, limits prescriber autonomy, and distorts the pharmaceutical market by government decree. While it removes some products from the prohibited list, it adds far more, expanding government control over what can be prescribed. In a free market, patients and doctors — not civil servants — should determine which products are appropriate. The NHS budget constraint argument does not justify specific product prohibitions; broader cost-control mechanisms would be less distortive. This is precisely the kind of regulatory intervention that suppresses supply, distorts incentives, and picks winners and losers in the marketplace.